BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 31100237)

  • 1. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting.
    Berge V; Thompson T; Blackman D
    Scand J Urol Nephrol; 2007; 41(3):198-203. PubMed ID: 17469027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies.
    Touijer KA; Karnes RJ; Passoni N; Sjoberg DD; Assel M; Fossati N; Gandaglia G; Eastham JA; Scardino PT; Vickers A; Cozzarini C; Montorsi F; Briganti A
    Eur Urol; 2018 Jun; 73(6):890-896. PubMed ID: 29042125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
    Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
    Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
    Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY
    Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer.
    Stranne J; Brasso K; Brennhovd B; Johansson E; Jäderling F; Kouri M; Lilleby W; Meidahl Petersen P; Mirtti T; Pettersson A; Rannikko A; Thellenberg C; Akre O
    Scand J Urol; 2018; 52(5-6):313-320. PubMed ID: 30585526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer.
    Herlemann A; Cowan JE; Washington SL; Wong AC; Broering JM; Carroll PR; Cooperberg MR
    Eur Urol; 2024 Jun; 85(6):565-573. PubMed ID: 37858454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy versus watchful waiting for prostate cancer.
    Hegarty J; Beirne PV; Walsh E; Comber H; Fitzgerald T; Wallace Kazer M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD006590. PubMed ID: 21069689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit.
    Gupta M; Patel HD; Schwen ZR; Tran PT; Partin AW
    BJU Int; 2019 Feb; 123(2):252-260. PubMed ID: 29626845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4).
    Andersson SO; Andrén O; Lyth J; Stark JR; Henriksson M; Adami HO; Carlsson P; Johansson JE
    Scand J Urol Nephrol; 2011 Apr; 45(3):177-83. PubMed ID: 21265595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy.
    Adam M; Tennstedt P; Lanwehr D; Tilki D; Steuber T; Beyer B; Thederan I; Heinzer H; Haese A; Salomon G; Budäus L; Michl U; Pehrke D; Stattin P; Bernard J; Klaus B; Pompe RS; Petersen C; Huland H; Graefen M; Schwarz R; Huber W; Loeb S; Schlomm T
    Eur Urol; 2017 Mar; 71(3):330-336. PubMed ID: 27887941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
    Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
    Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
    Lubeck DP; Grossfeld GD; Carroll PR
    Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
    Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A
    Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of randomized trials in localized prostate cancer.
    Alibhai SM; Klotz LH
    Can J Urol; 2004 Feb; 11(1):2110-7. PubMed ID: 15003149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial results.
    Abbas F; Kaplan M; Soloway MS
    Br J Urol; 1996 Mar; 77(3):423-8. PubMed ID: 8814850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.